TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8973987

Group type: EXPERIMENTAL
Intervention: 0.6 gm, 1.2 gm, and 1.8 gm doses of oxaprozin given on an empty stomach in a randomized, crossover trial (n = 35)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 1.2 gm once daily for 8 days (n = 12)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 1.8 gm once daily for 8 days (n = 24)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Multiple-dose administration
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Single-dose administration
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Repetitive dosing of oxaprozin
Number of subjects: 71
Study: 1383592

Group type: EXPERIMENTAL
Intervention: rheogluman
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 55
Study: 3902038

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Chlormethiazole
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 30796580

Group type: EXPERIMENTAL
Intervention: Risk-tailored group intervention
Number of subjects: 354

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 354
Study: 30222367

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27081014

Group type: EXPERIMENTAL
Intervention: Coronary Computed Tomography Angiography (CCTA)
Number of subjects: 4146

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 4146
Study: 25174283

Group type: EXPERIMENTAL
Intervention: Tratinterol hydrochloride 50 μg/d
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tratinterol hydrochloride 100 μg/d
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Tratinterol hydrochloride 150 μg/d
Number of subjects: 72
Study: 22815653

Group type: EXPERIMENTAL
Intervention: Community-based nursing intervention (HQP program)
Number of subjects: 1736

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1736
Study: 20307380

Group type: EXPERIMENTAL
Intervention: Bypass-surgery-first
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon-angioplasty-first
Number of subjects: 0
Study: 18834786

Group type: EXPERIMENTAL
Intervention: Oral coenzyme Q10, 150 to 180 mg/d, for 7 to 10 days preoperatively
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no antioxidant or placebo)
Number of subjects: 30
Study: 16103233

Group type: EXPERIMENTAL
Intervention: Quartile of patients with the biggest average decrease in hemoglobin (from 14.2 to 12.6 g/dL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing hemoglobin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lack of anemia at baseline and increases in hemoglobin over 12 months
Number of subjects: 0
Study: 11967028

Group type: EXPERIMENTAL
Intervention: Somatostatin alone (0.1 microg/kg/min)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Somatostatin + low dose insulin (0.1 mU/kg/min)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Somatostatin + high dose insulin (1.5 mU/kg/min)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Insulin (1.5 mU/kg/min) + somatostatin
Number of subjects: 46
Study: 10589750

Group type: EXPERIMENTAL
Intervention: IT DepoCyt (50 mg doses, up to six doses over 3 months)
Number of subjects: 61

Group type: COMPARATOR
Intervention: IT methotrexate (10 mg doses, up to sixteen doses over 3 months)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: IT DepoCyt
Number of subjects: 61

Group type: COMPARATOR
Intervention: IT methotrexate
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: DepoCyt
Number of subjects: 61
Study: 7854529

Group type: EXPERIMENTAL
Intervention: Boston Naming Test (BNT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peabody Picture Vocabulary Test‐Revised (PPVT‐R)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Word Fluency Test
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Shortened Token Test
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Modified Reporter's Test
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis of BNT and PPVT‐R
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis of all measures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AD subjects trends
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison with NE group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of subjects completing less than four sessions vs. those completing all four
Number of subjects: 60
Study: 1378139

Group type: EXPERIMENTAL
Intervention: 25 mg carvedilol b.i.d.
Number of subjects: 166

Group type: COMPARATOR
Intervention: 20 mg nifedipine sustained-release (SR)
Number of subjects: 166
Study: 6150180

Group type: COMPARATOR
Intervention: Pasteurised human milk and formula
Number of subjects: 226

Group type: COMPARATOR
Intervention: Raw human milk
Number of subjects: 226

Group type: COMPARATOR
Intervention: Pasteurised human milk
Number of subjects: 226

Group type: COMPARATOR
Intervention: Raw human milk and formula
Number of subjects: 226
Study: 30387538

Group type: EXPERIMENTAL
Intervention: Ostomy barrier with ceramide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ostomy barrier without ceramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TEWL measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual observation of erythema
Number of subjects: 0
Study: 26712530

Group type: EXPERIMENTAL
Intervention: Autogenic drainage (AD)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Slow expiration with glottis opened in lateral posture (ELTGOL)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Temporary positive expiratory pressure (TPEP)
Number of subjects: 31
Study: 24507168

Group type: EXPERIMENTAL
Intervention: Rhythm-control strategy
Number of subjects: 2105

Group type: EXPERIMENTAL
Intervention: Lenient rate-control
Number of subjects: 2105

Group type: COMPARATOR
Intervention: Strict rate-control
Number of subjects: 2105

Group type: EXPERIMENTAL
Intervention: Heart failure with preserved systolic function
Number of subjects: 2105

Group type: EXPERIMENTAL
Intervention: Heart failure with decreased systolic function
Number of subjects: 2105
Study: 22105463

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21152040

Group type: EXPERIMENTAL
Intervention: Amusic patients with right hemisphere damage (RHD)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Amusic patients with damage to the auditory cortex (AC)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Amusic patients (both with and without AC damage)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Non-amusic patients
Number of subjects: 53
Study: 17535489

Group type: EXPERIMENTAL
Intervention: Volitional intervention (overcoming motivational barriers)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Motivational intervention (implementation intention)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198
Study: 16273135

Group type: EXPERIMENTAL
Intervention: Meptin [HFA] 20 microg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Meptin [CFC] 20 microg
Number of subjects: 28
Study: 12393768

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate 30 mg kg(‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 7
Study: 9971850

Group type: EXPERIMENTAL
Intervention: Vesta endometrial ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional endometrial resection and rollerball ablation
Number of subjects: 0
Study: 7763157

Group type: EXPERIMENTAL
Intervention: Injection of 90 mL of saline and dextrose into the knee joint cavity
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no injection)
Number of subjects: 20
Study: 2155569

Group type: EXPERIMENTAL
Intervention: 6‐month regimen (self‐administered isoniazid and rifampin daily for 24 weeks, plus pyrazinamide daily during the first 8 weeks)
Number of subjects: 1451

Group type: EXPERIMENTAL
Intervention: 6‐month regimen
Number of subjects: 1451
Study: 6455969

Group type: EXPERIMENTAL
Intervention: Biotin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Essential fatty acid treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 30325422

Group type: EXPERIMENTAL
Intervention: Inverse probability weighting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selection bias
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lipoprotein(a)
Number of subjects: 0
Study: 28050922

Group type: EXPERIMENTAL
Intervention: Abdominal paracentesis drainage (APD)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Non-abdominal paracentesis drainage (non-APD)
Number of subjects: 161
Study: 26745361

Group type: EXPERIMENTAL
Intervention: Relaxation exercise program for 6 months
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control group (no intervention for the first 6 months)
Number of subjects: 384
Study: 24304099

Group type: EXPERIMENTAL
Intervention: CAF + ADM
Number of subjects: 48

Group type: COMPARATOR
Intervention: CAF
Number of subjects: 48
Study: 22149929

Group type: EXPERIMENTAL
Intervention: Mouth rinse containing zinc acetate (0.3%) and chlorhexidine diacetate (0.025%) with adjunct tongue scraping
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mouth rinse containing zinc acetate (0.3%) and chlorhexidine diacetate without adjunct tongue scraping
Number of subjects: 21

Group type: COMPARATOR
Intervention: Inactive rinse sequence with tongue scraping
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Active rinse sequence with or without tongue scraping
Number of subjects: 21
Study: 21381407

Group type: EXPERIMENTAL
Intervention: Probiotic (Bioflora) containing Lactobacillus casei, Lactobacillus plantarum, Streptococcus faecalis, and Bifidobacterium brevis, 5 ml bid for 5 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Metronidazol (Flagyl), 500 mg bid for 5 days
Number of subjects: 50
Study: 17981316

Group type: EXPERIMENTAL
Intervention: Lara Asthma Symptom Scale (LASS)
Number of subjects: 383
Study: 15091283

Group type: EXPERIMENTAL
Intervention: 10-hour nightshift schedule
Number of subjects: 0

Group type: COMPARATOR
Intervention: 8-hour nightshift schedule
Number of subjects: 0
Study: 12467131

Group type: COMPARATOR
Intervention: PUFA diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Soy diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 14
Study: 9665010

Group type: EXPERIMENTAL
Intervention: Prograf (0.2 mg/kg per day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Neoral (8 mg/kg per day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Prograf
Number of subjects: 80

Group type: COMPARATOR
Intervention: Neoral
Number of subjects: 80
Study: 8580802

Group type: EXPERIMENTAL
Intervention: Primary chemotherapy (adriamycin-containing) followed by involved-field radiotherapy; chemotherapy combinations were CHOP (18 patients) and ProMACE/MOPP (8 patients).
Number of subjects: 26

Group type: COMPARATOR
Intervention: Primary chemotherapy (adriamycin-containing) without radiotherapy.
Number of subjects: 26
Study: 2635496

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam 0.3 mg/kg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous thiopental 6.0 mg/kg
Number of subjects: 9
Study: 1274890

Group type: EXPERIMENTAL
Intervention: Nutrition education program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31324490

Group type: EXPERIMENTAL
Intervention: HIV
Number of subjects: 7422

Group type: COMPARATOR
Intervention: No HIV (Control group)
Number of subjects: 7422

Group type: EXPERIMENTAL
Intervention: Having at least 1 comorbidity
Number of subjects: 7422
Study: 29154054

Group type: EXPERIMENTAL
Intervention: Chamomile extract capsules (200mg) twice a day for 28 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wheat flour capsules (200mg) twice a day for 28 days (Control)
Number of subjects: 60
Study: 25950160

Group type: EXPERIMENTAL
Intervention: RelyX ARC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SeT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cavity
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sound teeth
Number of subjects: 60
Study: 23203401

Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal vaginoplasty
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic sigmoid vaginoplasty
Number of subjects: 40
Study: 21620309

Group type: EXPERIMENTAL
Intervention: Experimental group received an additional 30-minute session on safe and effective use of heat, cold, and relaxation breathing, along with hot and cold packs and relaxation breathing instruction for 2 weeks.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group attended a 30-minute educational session on safe use of over-the-counter medications.
Number of subjects: 53
Study: 20170044

Group type: EXPERIMENTAL
Intervention: New drug
Number of subjects: 0
Study: 16957999

Group type: EXPERIMENTAL
Intervention: Nocturnal hydration (NH)
Number of subjects: 0
Study: 15243277

Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: EPT (1 mg 17beta‐estradiol combined with 0.5 mg norethisterone acetate)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 11403659

Group type: EXPERIMENTAL
Intervention: Intracardiac microaxial pump (Group 1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass setup (Group 2)
Number of subjects: 42
Study: 9039174

Group type: EXPERIMENTAL
Intervention: Itraconazole, 200 mg twice daily for the first week of each month for 2 consecutive months
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 73
Study: 8297546

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluvastatin with cholestyramine (CME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluvastatin with niacin and propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluvastatin in patients receiving digoxin
Number of subjects: 0
Study: 3306545

Group type: EXPERIMENTAL
Intervention: Topical Healon
Number of subjects: 38

Group type: COMPARATOR
Intervention: Balanced salt solution
Number of subjects: 38
Study: 30376866

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E vaccine
Number of subjects: 195
Study: 27410770

Group type: EXPERIMENTAL
Intervention: CO inhalation (1.2 ml kg(‐1) CO for 30 seconds once per day for 10 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo inhalation (room air)
Number of subjects: 18
Study: 24211857

Group type: EXPERIMENTAL
Intervention: No-touch isolation technique
Number of subjects: 850

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 850
Study: 22516905

Group type: EXPERIMENTAL
Intervention: short‐set long‐interval condition (SSLI; 12 sets of 3 repetitions with a 60‐second interval between sets)
Number of subjects: 19

Group type: COMPARATOR
Intervention: short‐set short‐interval condition (SSSI; 12 sets of 3 repetitions with a 27.3‐second interval between sets)
Number of subjects: 19

Group type: COMPARATOR
Intervention: long‐set long‐interval (LSLI; 6 sets of 6 repetitions with a 60‐second rest interval between sets)
Number of subjects: 19
Study: 20098455

Group type: EXPERIMENTAL
Intervention: Natalizumab treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: G-CSF mobilization
Number of subjects: 0
Study: 18003764

Group type: EXPERIMENTAL
Intervention: Complete remission
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Partial remission
Number of subjects: 86

Group type: COMPARATOR
Intervention: No remission
Number of subjects: 86
Study: 16441791

Group type: EXPERIMENTAL
Intervention: Cerasorb (beta-tricalcium phosphate)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Autogenous bone graft
Number of subjects: 17
Study: 15182393

Group type: EXPERIMENTAL
Intervention: EPA (2.0 g/d)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GLA (2.0 g/d)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: STA (1.0 g/d) + GLA (0.9 g/d)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: STA (<1.0 g/d)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: EPA or GLA (2.0 g/d)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 7
Study: 11777488

Group type: EXPERIMENTAL
Intervention: Contraceptive patch (ORTHO EVRA/EVRA) applied 1/week for three cycles (3 weeks/cycle)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Contraceptive patch (ORTHO EVRA/EVRA)
Number of subjects: 24
Study: 9107203

Group type: EXPERIMENTAL
Intervention: Process consultation with nurse manager-consultant meetings
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Process consultation with nurse manager-consultant meetings (high-dose)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Process consultation with nurse manager-consultant meetings (low-dose)
Number of subjects: 13
Study: 8396092

Group type: EXPERIMENTAL
Intervention: Azithromycin 1 g single oral dose
Number of subjects: 143

Group type: COMPARATOR
Intervention: Doxycycline 100 mg bid for seven days
Number of subjects: 143
Study: 2418126

Group type: EXPERIMENTAL
Intervention: Group 1 RSV isolates
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Group 2 RSV isolates
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Intermediate character RSV isolates
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Community-acquired RSV isolates
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: RSV isolates from the 1981-1982 season
Number of subjects: 223
Study: 30993773

Group type: EXPERIMENTAL
Intervention: Passive heat stress (HEAT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mechanical forearm compression (CUFF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Handgrip exercise (HGEX)
Number of subjects: 10
Study: 29142136

Group type: EXPERIMENTAL
Intervention: ART plus maraviroc (MVC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard ART
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (MVC+ and MVC-)
Number of subjects: 18
Study: 26872112

Group type: EXPERIMENTAL
Intervention: Olanzapine plus metformin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Olanzapine plus placebo
Number of subjects: 25
Study: 25284435

Group type: EXPERIMENTAL
Intervention: Women with CAIS
Number of subjects: 46

Group type: COMPARATOR
Intervention: Typical (46,XY) men
Number of subjects: 46
Study: 22828553

Group type: EXPERIMENTAL
Intervention: Asphyxiated newborns (Group I)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control newborns (Group II)
Number of subjects: 75
Study: 20819493

Group type: EXPERIMENTAL
Intervention: NDP (40 mg/m(2)) and dexamethasone (10 mg) dissolved in 40 ml normal saline
Number of subjects: 68

Group type: COMPARATOR
Intervention: cDDP (40 mg/m(2)) and dexamethasone (10 mg) dissolved in 40 ml normal saline
Number of subjects: 68
Study: 18062117

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (100 mg daily for 10 days) with scaling and root planing (SRP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo with scaling and root planing (SRP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Comparison of GCF MMP-8 levels between flurbiprofen and placebo groups after therapy
Number of subjects: 58
Study: 15711671

Group type: EXPERIMENTAL
Intervention: Hepatitis B virus vaccine administered at 2, 3, 9 months concurrently with BCG (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hepatitis B virus vaccine administered at 3, 4, 9 months concurrently with BCG or other vaccines (n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hepatitis B virus vaccine administered at 0, 1, 6 months with no other coinciding vaccine (n=20)
Number of subjects: 60
Study: 12009349

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (0.312 mg/day for 21 days per cycle during six cycles, plus chlormadinone acetate 2 mg/day for the last 5 days of each cycle)
Number of subjects: 30
Study: 9718613

Group type: EXPERIMENTAL
Intervention: Pressure force applied during distraction test
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pressure force applied during compression test
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pressure force applied during pressure on the apex sacralis
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pressure force registration
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Inter-test reliability
Number of subjects: 17
Study: 7667327

Group type: EXPERIMENTAL
Intervention: Ethanol (EtOH, 0.65 + 0.35 g.kg‐1)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diazepam (DZ, 15 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diazepam (DZ, 30 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Lorazepam (LZ, 2 mg)
Number of subjects: 21
Study: 2782734

Group type: EXPERIMENTAL
Intervention: High dose inhaled salbutamol (HDS), 4,000 micrograms daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low dose inhaled salbutamol (LDS), 800 micrograms daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High dose inhaled salbutamol (HDS)
Number of subjects: 12
Study: 809835

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 60
Study: 31169883

Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 9737

Group type: EXPERIMENTAL
Intervention: Androstenedione
Number of subjects: 9737

Group type: EXPERIMENTAL
Intervention: 17‐hydroxyprogesterone
Number of subjects: 9737

Group type: EXPERIMENTAL
Intervention: DHEA‐S
Number of subjects: 9737

Group type: COMPARATOR
Intervention: Testosterone
Number of subjects: 9737
Study: 29179724

Group type: EXPERIMENTAL
Intervention: HeLP intervention
Number of subjects: 676
Study: 26434783

Group type: EXPERIMENTAL
Intervention: Counterconditioning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extinction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterconditioning with reward-US
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extinction with pain-US
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterconditioning with pain-US and reward-US
Number of subjects: 0